Amy E. DeZern, MD, MHS

Hematologist and medical oncologist at the Sidney Kimmel Comprehensive Cancer Center and assistant professor of oncology and medicine at the Johns Hopkins University School of Medicine in Baltimore, Maryland

From ASH Meeting on Hematologic Malignancies: How would you treat MDS that has not responded to azacitidine? Friday, September 1st, 2017
During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the meeting via an audience response system, but we want to know what you would do. Send in your responses for a chance to win an ASH Clinical News-themed prize!